| Views | |
|---|---|
| Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia | 925 |
| October 2025 | November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | |
|---|---|---|---|---|---|---|---|
| Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia | 31 | 30 | 14 | 23 | 23 | 41 | 16 |
| Views | |
|---|---|
| Dissertation_Tarland_Emilia.pdf | 739 |
| Disserttaion_Tarland_Emilia.pdf | 5 |
| Tarland_Emilia_2018_VETPROMOTION_DRUCKVERSION.pdf | 4 |
